Pages that link to "Q80059897"

The following pages link to The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression (Q80059897):

Displaying 31 items.

• Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota (Q27025039) (← links)
• Inflammasome in intestinal inflammation and cancer (Q27026882) (← links)
• Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles (Q27345472) (← links)
• The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer (Q33839949) (← links)
• Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer (Q33878967) (← links)
• Free immunoglobulin light chain (FLC) promotes murine colitis and colitis-associated colon carcinogenesis by activating the inflammasome (Q33899492) (← links)
• NOD-like receptors in intestinal homeostasis and epithelial tissue repair (Q33907548) (← links)
• Deregulated inflammasome signaling in disease (Q34212591) (← links)
• The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis (Q34313840) (← links)
• The Nlrp3 inflammasome: contributions to intestinal homeostasis (Q34762033) (← links)
• Protective role for caspase-11 during acute experimental murine colitis (Q34981595) (← links)
• Inflammasomes and Intestinal Tumorigenesis (Q36072651) (← links)
• Inflammasomes in Intestinal Inflammation and Cancer (Q36234946) (← links)
• The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders (Q36971550) (← links)
• Caspases as therapeutic targets. (Q37094016) (← links)
• Interleukin-18 and IL-18 binding protein (Q37220336) (← links)
• Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice. (Q37443636) (← links)
• The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway (Q37559676) (← links)
• The inflammasome regulatory pathway and infections: Role in pathophysiology and clinical implications (Q37800522) (← links)
• The interplay between autophagy and ROS in tumorigenesis (Q38062538) (← links)
• Integrative inflammasome activity in the regulation of intestinal mucosal immune responses (Q38065073) (← links)
• Interleukin-18 protein level is upregulated in adipose tissue of obese mice (Q38358581) (← links)
• Inflammasomes and intestinal inflammation (Q39237282) (← links)
• Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen (Q40397061) (← links)
• IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer (Q41903813) (← links)
• Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients. (Q42214761) (← links)
• Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones (Q42950789) (← links)
• Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice (Q48761759) (← links)
• Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut. (Q52728109) (← links)
• MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. (Q55488915) (← links)
• Inflammasome inhibitors: promising therapeutic approaches against cancer (Q93050768) (← links)